04:34:50 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Solarvest Bioenergy Inc
Symbol SVS
Shares Issued 59,945,372
Close 2023-01-30 C$ 0.10
Market Cap C$ 5,994,537
Recent Sedar Documents

Solarvest Bioenergy appoints Auld as CFO

2023-01-31 14:19 ET - News Release

Mr. Claes Ellegaard reports

SOLARVEST BIOENERGY INC. ANNOUNCES NEW CFO AND CORPORATE UPDATE ZOOM MEETING FOR SOLARVEST SHAREHOLDERS

Leslie Auld has been appointed Solarvest Bioenergy Inc.'s chief financial officer, effective Jan. 30, 2023.

Leslie Auld is a seasoned Financial Executive with over 30 years of relevant experience, including a background in Canadian and U.S. publicly listed companies in the pharmaceutical and diagnostic technology industries. She has held executive positions in biotechnology companies including Aeterna Zentaris and most recently as CFO of Tetra Bio-Pharma.

Ms. Auld is an experienced financial executive with extensive biotech experience. She is a CPA in Canada and holds a H. BSc., in Pharmacology and Toxicology from Western University and an MBA from the University of Toronto - Rotman School of Management.

Claes Ellegaard, CEO of Solarvest says "Leslie is an analytical, strategic, and solutions-oriented finance professional, who will bring a lot of expertise and experience to our organization and I'm very pleased that Leslie will join our team."

Mr. Ellegaard continues "Leslie will work hand-in-hand with Gerard Watts, who up till now has been acting as Solarvest's interim CFO. We are very grateful that Gerard will continue being part of the organization in this important transition phase where his experience will be invaluable".

Solarvest invite all shareholders to a corporate update meeting hosted on Zoom Wednesday February 8, 2023 at 4.15 pm EST. Please use following zoom link to participate in the call: https://zoom.us/j/92930790470

About Solarvest

Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.